Home » Authors » Omar Ford

Omar Ford

Articles

ARTICLES

New ventures: IROA forms to address concerns in diagnostics and imaging sector

July 15, 2009

MC has method to diagnose dementia before death

July 14, 2009

WPC offers med-tech companies haven for realizing innovation

July 13, 2009

Welch Allyn weighs in on impact of wireless patient monitoring

July 10, 2009

RCA has short-term benefits; still unclear over long-term results

July 9, 2009

Financings roundup: Relievant completes $20M round; Qliance gets $4 million

July 8, 2009

Financings roundup: SpineGuard completes round; nets $4M to reach $15M goal

July 6, 2009

New biomarker method could increase cancer diagnostic tests

July 2, 2009

Abbott Xience Prime DES gets CE mark, U.S. trial to follow

July 2, 2009

New biomarker method could increase cancer diagnostic tests

July 1, 2009

View All Articles by Omar Ford

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...